PSA1 (141-150), a prostate specific antigen 1 peptide, is used in the immunotherapy of cancer experiments.
PSA1 141-150 is a synthetic peptide fragment corresponding to amino acids 141 through 150 of the Prostate-Specific Antigen 1 (PSA1) protein sequence. As a defined segment of a well-characterized serine protease, this peptide is of significant interest in biochemical and molecular biology research, particularly in studies related to prostate biology, protein-protein interactions, and immunological recognition. Its precise sequence and structural fidelity make it a valuable tool for investigating the functional domains of PSA1, as well as for developing analytical assays and exploring post-translational modifications within the parent protein. PSA1 141-150's role as a model peptide facilitates targeted experimentation, enabling researchers to dissect complex biological processes with high specificity.
Epitope mapping: The PSA1 141-150 peptide serves as an effective reagent for mapping antibody binding sites within the PSA1 protein. By providing a defined linear epitope, it enables researchers to characterize monoclonal and polyclonal antibody specificity, screen for cross-reactivity, and validate antibody performance in immunoassays. This application is particularly valuable in the development and optimization of diagnostic reagents, where precise recognition of PSA1-derived sequences is critical for assay sensitivity and selectivity.
Protein interaction studies: As a representative fragment of the PSA1 protein, this peptide can be employed in binding assays and structural analyses to elucidate interactions with other biomolecules. Researchers use it to probe the molecular determinants of PSA1's interactions with endogenous inhibitors, substrates, or regulatory proteins. Such studies provide mechanistic insights into the structural requirements for binding and facilitate the identification of critical residues involved in protein-protein or protein-ligand recognition.
Mass spectrometry standards: PSA1 141-150 is widely utilized as a reference standard or internal control in mass spectrometry-based proteomic workflows. Its defined sequence and physicochemical properties allow for the calibration and validation of peptide identification protocols, quantification methods, and fragmentation pattern analyses. This enhances the reliability and reproducibility of proteomic data, supporting accurate detection and measurement of PSA1 or related peptides in complex biological samples.
Peptide-based assay development: The synthetic peptide is instrumental in the design and validation of biochemical assays, including enzyme-linked immunosorbent assays (ELISA) and competitive binding formats. By incorporating PSA1 141-150 as a target or competitor, researchers can establish robust platforms for quantifying PSA1 levels, screening for modulators, or assessing the functional activity of interacting molecules. Such assays are essential for both basic research and the development of analytical tools in the broader context of prostate biology and biomarker discovery.
Post-translational modification analysis: The defined sequence of PSA1 141-150 makes it amenable to studies focused on site-specific modifications, such as phosphorylation, methylation, or acetylation. Researchers can use the peptide as a substrate or control to investigate the enzymatic mechanisms responsible for such modifications, as well as to evaluate their impact on PSA1's biological activity. This approach supports a deeper understanding of the regulatory processes governing PSA1 function and provides a foundation for dissecting the role of post-translational modifications in prostate-related signaling pathways.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More